# NovalGen funding: rounds and investors > NovalGen has raised $15M across 6 rounds since 2021. Every round with its source. Source: https://millionrounds.com/company/novalgen (Millionrounds; every figure on the page links to its filing or article) United Kingdom · [Series A startup](https://millionrounds.com/companies) # Who invested in *NovalGen* 6 rounds we have observed, with the 0 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it. Biotech Raised 9 months ago Follow NovalGen and see its new rounds in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Fcompany%2Fnovalgen) Funding summary Updated 31 Oct 2026 **$15M** raised across 6 rounds since 2021, from 6 sources **$2.8M** Series A **$7.8M** Series A **$1.2M** Series A **$2.0M** Round **$806K** Round **$134K** Round - **Latest round:** Round, $134K Jan 2026 - **Biggest round:** $7.8M Series A · Aug 2022 - **Investors:** 0 See who backed them ## The funding story Each circle is a round, placed by date and sized by amount. The line above is the running total. 2022 2023 2024 2025 2026 **$2.8M** Series A **$7.8M** Series A **$1.2M** Series A **$2.0M** Round **$806K** Round **$134K** Round - **First round:** Series A, $2.8M - **Biggest round:** $7.8M - **Usual gap between rounds:** 6 months ## The rounds - **Jan 2026** Round **$134K** No investor was named in the report. Shares issued, filed with Companies House (SH01); no report of this raise yet - **Aug 2025** Round **$806K** No investor was named in the report. Shares issued, filed with Companies House (SH01); no report of this raise yet - **Feb 2025** Round **$2.0M** No investor was named in the report. Shares issued, filed with Companies House (SH01); no report of this raise yet - **Nov 2024** Series A **$1.2M** No investor was named in the report. Shares issued, filed with Companies House (SH01); no report of this raise yet - **Aug 2022** Series A **$7.8M** No investor was named in the report. Shares issued, filed with Companies House (SH01); no report of this raise yet - **Sept 2021** Series A **$2.8M** No investor was named in the report. Shares issued, filed with Companies House (SH01); no report of this raise yet ## Funding filed with regulators NovalGen filed 25 raises, $15M in all. Filings say how much was sold and to how many investors; they never name the investors. - Jan 2026 **$134K** UK share allotment - Oct 2025 **$133K** UK share allotment - Oct 2025 **$134K** UK share allotment - Sept 2025 **$169K** UK share allotment - Sept 2025 **$169K** UK share allotment - Aug 2025 **$202K** UK share allotment - Jun 2025 **$343K** UK share allotment - May 2025 **$539K** UK share allotment - Apr 2025 **$401K** UK share allotment - Mar 2025 **$259K** UK share allotment - Feb 2025 **$504K** UK share allotment - Nov 2024 **$1.2M** UK share allotment - Jul 2023 **$412K** UK share allotment - Jun 2023 **$410K** UK share allotment - May 2023 **$498K** UK share allotment - May 2023 **$398K** UK share allotment - Mar 2023 **$392K** UK share allotment - Feb 2023 **$598K** UK share allotment - Dec 2022 **$872K** UK share allotment - Nov 2022 **$850K** UK share allotment - Oct 2022 **$810K** UK share allotment - Sept 2022 **$823K** UK share allotment - Aug 2022 **$868K** UK share allotment - Aug 2022 **$902K** UK share allotment - Sept 2021 **$2.8M** UK share allotment ## Founders and team From NovalGen's own website: 1 founder, 12 on the team. **Professor Amit Nathwani** Founder & CEO - **Dr Kieran O’Donovan** COO & CTO - **Dr David Granger** VP R&D - **Alexander Boches** Finance Director - **Bharat Thakrar** Director - **Dr Laurent Fischer** Chairman - **Dr Simon Goldman** Director - **Dr Vincent Muczynski** Director Biology - **Nitin Shah** Finance Director - **Professor David Venables** Director - **Professor Mike Owen** Director - **Samit Hathi** Director - **Scott Clarke** Director ## Also claim to have backed them This firm lists NovalGen as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above. [AlbionVC](https://millionrounds.com/fund/albionvc) VC firm Per its own site ## Quick answers about NovalGen ### How much has NovalGen raised? NovalGen has raised $15M across 6 rounds since 2021. ### When did NovalGen last raise? NovalGen's most recent round, $134K, was in Jan 2026. ### What was NovalGen's biggest round? NovalGen's largest round on record is $7.8M (Series A), in Aug 2022. ### What stage is NovalGen at? NovalGen's latest named round is a Series A, in Nov 2024. ### Where is NovalGen based? NovalGen is based in the United Kingdom. ## Companies like NovalGen In the same sector, and raised in the last eighteen months. [**SAVA** $21M · Oct 2026](https://millionrounds.com/company/sava)[**HydRegen** $12M · Oct 2026](https://millionrounds.com/company/hydregen)[**OMass Therapeutics** $442M · Oct 2026](https://millionrounds.com/company/omass-therapeutics)[**CMR Surgical** $1.1B · Oct 2026](https://millionrounds.com/company/cmr-surgical)[**Living Optics** $61M · Oct 2026](https://millionrounds.com/company/living-optics)[**Bactobio** $18M · Oct 2026](https://millionrounds.com/company/bactobio) ## Find investors like these Search every investor by what they have actually funded, then narrow to your stage and market. Free. Open the investor searchOr these rounds in the app